HR4698Referred to Committee

PAAW Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-23
Introduced
15
Cosponsors
HR
ⓘ
Type

Sponsor

Nancy Mace
Nancy Mace
Republican · SC · Representative
Votes with party: 94.5% (477 recorded votes)

Full profile: /officials/M000194

Source: Congress.gov · FEC

Cosponsors (15)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-07-23

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

The proposal would establish new protections and requirements for how pharmaceutical companies handle and report information about their drugs' safety and effectiveness. It aims to give patients and healthcare providers better access to data about medication risks and benefits so they can make more informed decisions about treatment options. The measure would affect drug manufacturers, healthcare professionals, and patients who rely on prescription and over-the-counter medications.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.